Relationship between intermedin and atrial fibrosis in patients of hypertension combined with atrial fibrillation.
- Author:
Jiayue FENG
;
Xiaoping CHEN
;
Liyan WAN
;
Sen HE
;
Yufei ZHOU
;
Shixi WAN
- Publication Type:Journal Article
- MeSH:
Atrial Fibrillation;
physiopathology;
Female;
Humans;
Hypertension;
physiopathology;
Male;
Peptide Hormones;
blood;
Transforming Growth Factor beta1;
blood
- From:
Journal of Biomedical Engineering
2014;31(5):1097-1110
- CountryChina
- Language:Chinese
-
Abstract:
This study was aimed to evaluate the relationship between the changes of plasma intermedin (IMD) and atrial fibrosis in hypertensive patients with atrial fibrillation. During the period from 2010 to 2011, appropriate 150 subjects of out-patients (female 50%, male 50%) were selected in West China Hospital, Sichuan University, and were divided into three groups: the hypertension-only group, the hypertension combined with paroxysmal atrial fibrillation group and the hypertension combined with persistent atrial fibrillation group. Firstly, we collected the Physical examination results and medical history records of the patients. We then performed ultrasound cardiogram and blood biochemical tests on the patients. We also detected the plasma IMD and transforming growth factor β1 (TGF-β1) using ELISA. The results showed that compared with the hypertensive group, the plasma level of IMD, TGF-β1 and left atrium director (LAD) in the hypertensive combined with atrial fibrillation group were higher significantly. Compared with the paroxymal atrial fibrillation group, the levels of IMD, TGF-β1 and LAD were higher significantly in persistent atrial fibrillation group. Analysis of correlation and partial correlation showed that IMD was positively correlated with TGF-p1 (r=0.51, P<0. 001), IMD was positively correlated with LAD(r=0.59, P< 0.001), and TGF-β1 was positively correlated with LAD (r = 0.57, P < 0.001). The results suggest that IMD might suppress the pathophysiological process of atrial fibrillation.
